The combination of Curcumin and Doxorubicin on targeting PI3K/AKT/mTOR signaling pathway: an in vitro and molecular docking study for inhibiting the survival of MDA-MB-231.
Esha SarkarAkanksha KotiyaAfreen KhanRajabrata BhuyanSyed Tasleem RazaAparna MisraAbbas Ali MahdiPublished in: In silico pharmacology (2024)
The online version contains supplementary material available at 10.1007/s40203-024-00231-2.